CompaniesImmetacyte

Immetacyte

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

By Phase

PHASE1/PHASE2: 1

By Status

WITHDRAWN: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT04389229
Hover over trial bars to see details

Recent Trials

NCT04389229Lead Sponsor
OVSTAR TIL Trial (OVarian Cancer Co-STimulatory Antigen Receptor TIL Trial)
PHASE1/PHASE2Withdrawn
Started: Jul 1, 2020 · Completed: Jul 31, 2025